Design Therapeutics Statistics Share Statistics Design Therapeutics has 56.95M
shares outstanding. The number of shares has increased by 0.26%
in one year.
Shares Outstanding 56.95M Shares Change (YoY) 0.26% Shares Change (QoQ) 0.01% Owned by Institutions (%) 60.71% Shares Floating 31.11M Failed to Deliver (FTD) Shares 200 FTD / Avg. Volume 0.17%
Short Selling Information The latest short interest is 3.51M, so 6.16% of the outstanding
shares have been sold short.
Short Interest 3.51M Short % of Shares Out 6.16% Short % of Float 9.32% Short Ratio (days to cover) 24.07
Valuation Ratios The PE ratio is -7.04 and the forward
PE ratio is -5.01.
Design Therapeutics's PEG ratio is
0.27.
PE Ratio -7.04 Forward PE -5.01 PS Ratio 0 Forward PS 3.1 PB Ratio 1.44 P/FCF Ratio -8.04 PEG Ratio 0.27
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Design Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 29.31,
with a Debt / Equity ratio of 0.01.
Current Ratio 29.31 Quick Ratio 29.31 Debt / Equity 0.01 Debt / EBITDA -0.05 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-885.5K Employee Count 56 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 38.12% in the
last 52 weeks. The beta is 1.62, so Design Therapeutics's
price volatility has been higher than the market average.
Beta 1.62 52-Week Price Change 38.12% 50-Day Moving Average 4.5 200-Day Moving Average 4.61 Relative Strength Index (RSI) 73.58 Average Volume (20 Days) 116,803
Income Statement
Revenue n/a Gross Profit -596K Operating Income -62.38M Net Income -49.59M EBITDA -48.99M EBIT -49.59M Earnings Per Share (EPS) -0.88
Full Income Statement Balance Sheet The company has 22.56M in cash and 2.33M in
debt, giving a net cash position of 20.23M.
Cash & Cash Equivalents 22.56M Total Debt 2.33M Net Cash 20.23M Retained Earnings -227.21M Total Assets 222.89M Working Capital 211.05M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -43.1M
and capital expenditures -340K, giving a free cash flow of -43.45M.
Operating Cash Flow -43.1M Capital Expenditures -340K Free Cash Flow -43.45M FCF Per Share -0.77
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
